Home sleep study for patients with myasthenia gravis

J. H. Yeh, C. M. Lin, H. C. Chiu, C. H. Bai

研究成果: 雜誌貢獻文章

4 引文 (Scopus)

摘要

Objectives: The objective of the study was to examine predictors for sleep-disordered breathing (SDB) in patients with myasthenia gravis (MG) using Watch-PAT. Materials and Methods: We prospectively studied 58 consecutive patients with MG without respiratory symptoms for a full-night Watch-PAT with concomitant recording of the MG score and acetylcholine receptor antibody concentration and analyzed potential risk factors of SDB. Results: Twenty-four patients (41%) had definitive SDB, which was mild in 12 patients, moderate in six, and severe in six. Assessing risk factors with multivariate models, we found four significant predictors (BMI, age, male gender, and use of azathioprine); BMI was the most powerful predictor. The severity and prevalence of sleep-disordered breathing had no significant association with MG score, myasthenia stage, or seropositivity of acetylcholine receptor antibody. Conclusions: The prevalence of SDB in myasthenic patients with mild and moderate weakness was high when using the Watch-PAT. Both myasthenia-specific factors (use of azathioprine) and general predictors in terms of BMI, age, and male gender predisposed the development of SDB in patients with myasthenia gravis. Careful screening of patients with myasthenia gravis at risk of SDB using Watch-PAT might improve the quality of sleep and cardiovascular health through proper treatment of underlying SDB.

原文英語
頁(從 - 到)191-195
頁數5
期刊Acta Neurologica Scandinavica
132
發行號3
DOIs
出版狀態已發佈 - 2015

指紋

Myasthenia Gravis
Sleep Apnea Syndromes
Sleep
Azathioprine
Cholinergic Receptors
Antibodies
Muscle Weakness
Health

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

引用此文

Home sleep study for patients with myasthenia gravis. / Yeh, J. H.; Lin, C. M.; Chiu, H. C.; Bai, C. H.

於: Acta Neurologica Scandinavica, 卷 132, 編號 3, 2015, p. 191-195.

研究成果: 雜誌貢獻文章

Yeh, J. H. ; Lin, C. M. ; Chiu, H. C. ; Bai, C. H. / Home sleep study for patients with myasthenia gravis. 於: Acta Neurologica Scandinavica. 2015 ; 卷 132, 編號 3. 頁 191-195.
@article{4395f8130daf42f78858d01fc6825ebd,
title = "Home sleep study for patients with myasthenia gravis",
abstract = "Objectives: The objective of the study was to examine predictors for sleep-disordered breathing (SDB) in patients with myasthenia gravis (MG) using Watch-PAT. Materials and Methods: We prospectively studied 58 consecutive patients with MG without respiratory symptoms for a full-night Watch-PAT with concomitant recording of the MG score and acetylcholine receptor antibody concentration and analyzed potential risk factors of SDB. Results: Twenty-four patients (41{\%}) had definitive SDB, which was mild in 12 patients, moderate in six, and severe in six. Assessing risk factors with multivariate models, we found four significant predictors (BMI, age, male gender, and use of azathioprine); BMI was the most powerful predictor. The severity and prevalence of sleep-disordered breathing had no significant association with MG score, myasthenia stage, or seropositivity of acetylcholine receptor antibody. Conclusions: The prevalence of SDB in myasthenic patients with mild and moderate weakness was high when using the Watch-PAT. Both myasthenia-specific factors (use of azathioprine) and general predictors in terms of BMI, age, and male gender predisposed the development of SDB in patients with myasthenia gravis. Careful screening of patients with myasthenia gravis at risk of SDB using Watch-PAT might improve the quality of sleep and cardiovascular health through proper treatment of underlying SDB.",
keywords = "acetylcholine receptor antibody, body mass index, myasthenia gravis, peripheral arterial tone, polysomnography, sleep-disordered breathing",
author = "Yeh, {J. H.} and Lin, {C. M.} and Chiu, {H. C.} and Bai, {C. H.}",
year = "2015",
doi = "10.1111/ane.12382",
language = "English",
volume = "132",
pages = "191--195",
journal = "Acta Neurologica Scandinavica",
issn = "0001-6314",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Home sleep study for patients with myasthenia gravis

AU - Yeh, J. H.

AU - Lin, C. M.

AU - Chiu, H. C.

AU - Bai, C. H.

PY - 2015

Y1 - 2015

N2 - Objectives: The objective of the study was to examine predictors for sleep-disordered breathing (SDB) in patients with myasthenia gravis (MG) using Watch-PAT. Materials and Methods: We prospectively studied 58 consecutive patients with MG without respiratory symptoms for a full-night Watch-PAT with concomitant recording of the MG score and acetylcholine receptor antibody concentration and analyzed potential risk factors of SDB. Results: Twenty-four patients (41%) had definitive SDB, which was mild in 12 patients, moderate in six, and severe in six. Assessing risk factors with multivariate models, we found four significant predictors (BMI, age, male gender, and use of azathioprine); BMI was the most powerful predictor. The severity and prevalence of sleep-disordered breathing had no significant association with MG score, myasthenia stage, or seropositivity of acetylcholine receptor antibody. Conclusions: The prevalence of SDB in myasthenic patients with mild and moderate weakness was high when using the Watch-PAT. Both myasthenia-specific factors (use of azathioprine) and general predictors in terms of BMI, age, and male gender predisposed the development of SDB in patients with myasthenia gravis. Careful screening of patients with myasthenia gravis at risk of SDB using Watch-PAT might improve the quality of sleep and cardiovascular health through proper treatment of underlying SDB.

AB - Objectives: The objective of the study was to examine predictors for sleep-disordered breathing (SDB) in patients with myasthenia gravis (MG) using Watch-PAT. Materials and Methods: We prospectively studied 58 consecutive patients with MG without respiratory symptoms for a full-night Watch-PAT with concomitant recording of the MG score and acetylcholine receptor antibody concentration and analyzed potential risk factors of SDB. Results: Twenty-four patients (41%) had definitive SDB, which was mild in 12 patients, moderate in six, and severe in six. Assessing risk factors with multivariate models, we found four significant predictors (BMI, age, male gender, and use of azathioprine); BMI was the most powerful predictor. The severity and prevalence of sleep-disordered breathing had no significant association with MG score, myasthenia stage, or seropositivity of acetylcholine receptor antibody. Conclusions: The prevalence of SDB in myasthenic patients with mild and moderate weakness was high when using the Watch-PAT. Both myasthenia-specific factors (use of azathioprine) and general predictors in terms of BMI, age, and male gender predisposed the development of SDB in patients with myasthenia gravis. Careful screening of patients with myasthenia gravis at risk of SDB using Watch-PAT might improve the quality of sleep and cardiovascular health through proper treatment of underlying SDB.

KW - acetylcholine receptor antibody

KW - body mass index

KW - myasthenia gravis

KW - peripheral arterial tone

KW - polysomnography

KW - sleep-disordered breathing

UR - http://www.scopus.com/inward/record.url?scp=85006476276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006476276&partnerID=8YFLogxK

U2 - 10.1111/ane.12382

DO - 10.1111/ane.12382

M3 - Article

VL - 132

SP - 191

EP - 195

JO - Acta Neurologica Scandinavica

JF - Acta Neurologica Scandinavica

SN - 0001-6314

IS - 3

ER -